Product Description:
HERTI 440MG Injection contains Trastuzumab, a monoclonal antibody used to treat HER2-positive breast cancer and gastric (stomach) cancer. It works by targeting and inhibiting the HER2 receptor, which helps slow down or stop the growth of cancer cells.
This injection is administered under the supervision of a healthcare professional, usually in a clinical or hospital setting. HERTI 440MG is part of a long-term cancer treatment plan and is used in combination with other chemotherapy medicines or as a monotherapy depending on the stage and condition.
Key Benefits:
Effective in treating HER2-positive breast cancer
Also used for HER2-positive gastric cancer
Helps reduce the risk of cancer spreading or coming back
Targeted therapy with proven clinical results
Usage Instructions:
Should be given by a doctor or a nurse only
Do not self-administer
Follow your oncologist’s advice strictly
Side Effects:
Common side effects may include fever, chills, nausea, headache, heart problems, and infusion-related reactions. Always consult your doctor for proper monitoring during treatment.
Storage Instructions:
Store in a refrigerator (2°C – 8°C)
Do not freeze
Keep out of reach of children
Disclaimer:
This product should be used only under medical supervision. Please consult your doctor before starting or stopping any medication.
Reviews
There are no reviews yet.